This Article Abstract Full Text (PDF) All Versions of this Article: 105/6/685    most recent hc0602.103617v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dybdahl, B. Articles by Sundan, A. Search for Related Content PubMed PubMed Citation Articles by Dybdahl, B. Articles by Sundan, A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Coronary Artery Bypass Surgery Coronary Artery Disease Related Collections Chronic ischemic heart disease CV surgery: coronary artery disease Cell signalling/signal transduction Growth factors/cytokines Ischemic biology - basic studies

(Circulation. 2002;105:685.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Inflammatory Response After Open Heart Surgery

Release of Heat-Shock Protein 70 and Signaling Through Toll-Like Receptor-4

Brit Dybdahl, MD; Alexander Wahba, MD, PhD; Egil Lien, PhD; Trude H. Flo, PhD; Anders Waage, MD, PhD; Nilofer Qureshi, PhD; Olav F.M. Sellevold, MD, PhD; Terje Espevik, PhD; Anders Sundan, PhD

From the Faculty of Medicine (B.D., E.L., T.H.F., T.E., A.S.), Institute of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, Trondheim, Norway; the Department of Cardiothoracic Surgery (A.W., O.F.M.S.), St Elisabeth Heart Centre, University Hospital of Trondheim, Norway; the Department of Medicine (A.W.), Section for Hematology, University Hospital of Trondheim, Norway; and the School of Medicine (N.Q.), Shock and Trauma Research Center, University of Missouri, Kansas City.

Correspondence to Dr Brit Dybdahl, Faculty of Medicine, Institute of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, Medisinsk Teknisk Forskningssenter, N-7489 Trondheim, Norway. E-mail brit.dybdahl{at}medisin.ntnu.no

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background— Coronary artery bypass grafting with the use of cardiopulmonary bypass is known to mediate an inflammatory response. The stress-inducible heat-shock protein (HSP) 70 has been detected in myocardial cells after CABG, and toll-like receptors (TLRs) are suggested as putative signaling receptors for the HSPs, mediating synthesis of inflammatory cytokines. The main aims of our study were to explore the release of HSP70 and the regulation of monocyte TLR-2 and TLR-4 expression after CABG.

Methods and Results— Twenty patients referred for elective CABG were included in this study. Using immunoassays, we detected HSP70 in plasma after CABG, with peak concentration immediately after surgery. Interleukin-6 in plasma reached peak concentration 5 hours after surgery. Monocyte CD14, TLR-2, and TLR-4 expression, as analyzed by flow cytometry, was initially downregulated. On day 1, CD14 expression normalized, whereas TLR-2 and TLR-4 expression was upregulated. TLR-4 was significantly upregulated even on postoperative day 2. Additional experiments revealed that peritoneal macrophages from control (C3H/HeN) mice responded to HSP70 with release of tumor necrosis factor, whereas macrophages from mutated TLR-4 (C3H/HeJ) mice were unresponsive. In vitro, human adherent monocytes responded to recombinant HSP70 with interleukin-6 and tumor necrosis factor release. CD14 and TLR-4 monoclonal antibodies inhibited the cytokine response.

Conclusions— In this study, we observed an immediate release of HSP70 into the circulation and a modulation of monocyte TLR-2 and TLR-4 expression after CABG. TLR-4 and CD14 appear to be involved in an HSP70-mediated activation of innate immunity.

Key Words: heat-shock proteins • toll-like receptors • inflammation • cardiopulmonary bypass • angina

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
It is well recognized that CABG with the use of cardiopulmonary bypass (CPB) causes an inflammatory response.^1–4 This may be related to the surgical trauma, myocardial ischemia and reperfusion, anesthesia, cardioplegia, and the heart-lung machine. It has been suggested that microbial invasion may contribute to the postoperative inflammatory response.⁵ Nevertheless, noninfectious, endogenous danger signals may be released during surgery, thus activating innate immunity.

Heat-shock proteins (HSPs) are abundant intracellular proteins found in both prokaryotic and eukaryotic organisms. Their main function appears to be as chaperones, involved in protein folding and transport.⁶ The HSP70 family, located in the cytosol and the nucleus of the cell, is the most conserved and the best-studied class of HSPs and includes the constitutive HSP73 (HSC70) and the stress-inducible HSP70 (HSP72).⁷ Myocardial ischemia induces HSP70 as a stress response,⁷ and HSP70 is increased in atrial tissue of patients with unstable angina.⁸ Demidov and coworkers⁹ found induction of HSP70 in myocardial cells in 40% of 33 patients undergoing CABG. Circulating inducible HSP70 after CABG has, to our knowledge, not been demonstrated previously.

The receptor complex of CD14, toll-like receptor (TLR)-4, and MD-2 on monocytes appears to be the principal receptor complex of lipopolysaccharide (LPS), mediating activation of nuclear factor-kappa B and synthesis of proinflammatory cytokines.^10–14 It appears that TLR-2 is important for cell activation of some Gram-positive bacteria.^14,15 Chen et al¹⁶ observed that HSP60 had immunostimulatory properties when added to macrophage cultures. Extracellular human HSP60 and HSP70 appear to activate innate immunity by a CD14-dependent mechanism,^17,18 and TLR-4 is suggested to be involved in HSP60 signaling.¹⁹

We hypothesized that modulation of monocyte TLR-2 and TLR-4 expression was induced by heart surgery. Accordingly, the first aim of the present study was to investigate the monocyte surface expression of TLR-2 and TLR-4 in patients through the first 2 days after CABG. Our second aim was to explore the potential release of HSP70 into plasma, hypothesizing HSP70 to be an endogenous ligand for TLRs on monocytes, thus mediating synthesis of proinflammatory cytokines.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Patients
From April through June 2000, 20 patients referred for elective CABG at the Department of Cardiothoracic Surgery/St Elisabeth Heart Center, University Hospital of Trondheim, Norway, were included in the study. The patients had angiographically verified 3-vessel or in a few cases 2-vessel disease, were <75 years old, and before surgery had no signs of infection. Emergency cases and patients undergoing combined procedures or reoperations were excluded. The regional ethics committee approved the study protocol, and informed consent was obtained from each subject.

Anesthesia and Surgical Procedure
All patients underwent a routine procedure with median sternotomy and use of CPB. Anesthesia was induced with diazepam, fentanyl, thiopental, and pancuronium and maintained with isoflurane, fentanyl, and nitrous oxide until the start of CPB. We used cephalothin as perioperative antibiotic prophylaxis. The activated clotting time was maintained >480 seconds during CPB, and CPB was performed with nonpulsatile flow of 2.4 L/min per m² body surface area with a roller-pump. Patients were cooled down to 34°C at the beginning of CPB, and active rewarming was started during the last distal coronary anastomosis. St Thomas cardioplegic solution No. I was used in 17 patients; 3 patients had cold blood cardioplegia. A membrane oxygenator with synthetic, biocompatible surfaces (Maxima, Medtronic) was used for all patients. The pump prime consisted of 1800 mL Ringer’s solution and 7500 IU heparin. After CPB, heparin was neutralized with protamine sulfate until the preoperative activated clotting time was achieved.

Blood Sampling
Blood samples were taken through an indwelling radial artery catheter before induction of anesthesia, 30 minutes after completion of surgery, 5 hours thereafter, and at 8 AM on days 1 (19 hours) and 2 (43 hours) after surgery. VACUTAINER CPT cell preparation tubes with sodium heparin (Becton Dickinson VACUTAINER Systems) were used, and samples were centrifuged within 20 minutes of sampling. After washing, peripheral blood mononuclear cells (PBMCs) were resuspended in freezing medium. Both plasma and PBMC samples were stored at -80°C until analysis.

Plasma Analyses
Interleukin (IL)-6, tumor necrosis factor (TNF)-, and IL-1ß in plasma were measured with Quantikine Human Immunoassays (R&D Systems, Inc) with sensitivities 0.70 pg/mL, 4.4 pg/mL, and 1 pg/mL, respectively. HSP70 in plasma was detected with Hsp70 EIA Kit, sensitivity 200 pg/mL (StressGen Biotechnologies Corp).

Flow Cytometry
Flow cytometric analyses were carried out with the use of an Epics XL-MCL flow cytometer and Expo 32 ADC software (Beckman Coulter Inc). All PBMC samples from each patient were analyzed consecutively, with identical flow cytometer settings and immunostaining procedure. We used PBMCs from one healthy person as an internal control each time flow cytometry was performed. Control experiments indicated that freezing of PBMC samples did not change monocyte surface CD14, TLR-2, or TLR-4 expression when compared with fresh cells (data not shown). The PBMC samples were incubated with the following monoclonal antibodies (mAbs) in different wells: Fluorescein isothiocyanate (FITC)-conjugated human CD14 mAb clone 18D11 (Diatec) with FITC–goat anti-mouse (GAM) (Becton Dickinson) as control. We used an Alexa488-conjugated (Molecular Probes) TLR-2 mAb (TL 2.1)¹⁶ and an Alexa488-conjugated TLR-4 mAb (HTA125, gift of Kensuke Miyake, Saga Medical School, Japan)¹³ with an Alexa488-stained, isotype-matched irrelevant antibody as control. Gating of monocytes was done during analyses according to forward and side-scatter dot plots, and the mean fluorescence intensity (MFI) of 5000 gated monocytes was measured. To ease data interpretation, preoperative MFI values were set to 100%, and postoperative values were expressed as percentages of the initial value for each patient.

In Vitro Studies
Peritoneal macrophages from C3H/HeN and C3H/HeJ mice (Harlan Ltd, Oxon, UK) were collected by lavage 3 days after intraperitoneal injection of 3% thioglycollate (3 mL, Difco). Cells (5x10⁵ cells/well in 24-well dishes) were adhered for 2 hours, and after washing, macrophages were stimulated in Roswell Park Memorial Institute (RPMI) 1640 medium 10% FCS for 6 hours in a total volume of 0.25 mL. Recombinant human (rhu) HSP70 (SPP-755, StressGen Biotechnologies Corp, Victoria, Canada) in various concentrations, Escherichia coli K235 LPS (protein <0.008%), 10 ng/mL (gift of S. Vogel, Uniformed Services University of the Health Sciences, Bethesda, Md), and the 47L synthetic lipohexapeptide (based on the 47-kDa Treponema pallidum lipoprotein) 10 µg/mL (gift of T. Sellati and J.D. Radolf, University of Connecticut) were used as stimuli. TNF in cell-free supernatants were measured by the WEHI 164 clone 13 bioassay.²⁰

PBMCs were isolated from human buffy coats with Lymphoprep (Nycomed Amersham), as described by the manufacturer. Monocytes were isolated by adherence to plastic (90 minutes, 37°C). The cells were preincubated in RPMI 1640 medium for 30 minutes with 10 µg/mL of anti–TLR-2 (TL2.1), anti–TLR-4 (HTA125), or anti-CD14 (3C10, American Type Culture Collection, Manassas, Va) before addition of LPS or rhu HSP70 in various concentrations, and the incubation continued for 7 hours at 37°C when supernatants were collected and stored at -20°C. Polymyxin B (5 µg/mL) (Sigma) and the lipid A analogue Rhodobacter sphaeroides lipid A (RSLA)²¹ (10 µg/mL) were added directly before the stimuli. TNF was measured by the WEHI 164 clone 13 bioassay²⁰ and IL-6 by the B9 cell proliferation assay.²² The endotoxin content of rhu HSP70 (10 µg/mL), measured by the Limulus amebocyte lysate assay (Chromogenix), was 1 EU/mL (range, 0.8 to 1.2 EU/mL).

Statistics
The SPSS Version 10.05 and GraphPad Prism Version 3.0 were used. Statistical comparisons were made by means of the Friedman test for repeated measures on nonparametric data and Dunn’s multiple comparison test as post hoc test. Differences were considered statistically significant at level of P<0.05. For correlation analysis, we used Pearson correlation (2-tailed).

	Results

Top Abstract Introduction Methods Results Discussion References

 
Patients
Demographic data and postoperative adverse events are summarized (Tables 1 and 2, respectively). Blood samples were collected at 5 different time points in 18 patients. From the remaining 2 patients, we obtained only 4 samples. Fifteen patients were diagnosed as having stable angina pectoris, whereas 5 had unstable angina before surgery. The surgical procedure was uncomplicated in all of the patients, but one was receiving CPB for a second time before skin closure. None of the patients received blood transfusions during the operation, but 3 were transfused after surgery (Table 1). Three patients had clinical signs of pneumonia after blood sampling was completed (Table 2). Our study population showed an increase in white cell count and a decrease in hemoglobin level and platelet count during the first 2 postoperative days (Table 3).

View this table: [in this window] [in a new window]   Table 1. Demographic Data and Clinical Characteristics of 20 Patients Undergoing Elective CABG Operations With CPB

View this table: [in this window] [in a new window]   Table 2. Incidence of Postoperative Adverse Events

View this table: [in this window] [in a new window]   Table 3. Laboratory Data

Plasma Concentration of HSP70 and IL-6
Median IL-6 concentrations measured before surgery and at different time points through the first 2 days after surgery were 0, 43, 107, 93, and 118 pg/mL, respectively (Figure 1A). Correspondingly, median inducible HSP70 concentrations in plasma were 0, 1809, 1879, 0, and 0 pg/mL, respectively (Figure 1B). The quantity of IL-6 (area under curve the first day after surgery) for each patient was correlated (r=0.57; P<0.01) to the quantity of HSP70. IL-1ß and TNF- were not detected in any samples.

View larger version (14K): [in this window] [in a new window]   Figure 1. Plasma IL-6 and HSP70 concentration (median and interquartile ranges) after CABG. A, IL-6. All postoperative IL-6 values were significantly different from the preoperative value (P<0.05 for the first postoperative concentration, P<0.001 for the later concentrations). B, HSP70. P<0.001 for values measured at 0 and 5 hours after surgery compared with preoperative concentration.

Regulation of the Monocyte Surface Expression of CD14, TLR-2, and TLR-4
As measured by flow cytometry, median CD14 MFI values at 0, 5, 19, and 43 hours after surgery were 75% (P<0.001), 93% (NS), 111% (NS), and 101% (NS), compared with preoperative values, respectively (Figure 2A). The corresponding median TLR-2 MFI values were 73% (P<0.01), 95% (NS), 123% (P<0.001), and 112% (NS), respectively (Figure 2B). The postoperative TLR-4 median MFI values were 86% (NS), 116% (NS), 144% (P<0.001), and 153% (P<0.001), respectively (Figure 2C). As can be expected, interindividual variations in the CD14, TLR-2, and TLR-4 MFI values were observed. Nevertheless, all the patients responded to the CABG operation in a similar manner regarding the postoperative regulation of these receptors. A representative flow cytometry histogram showing TLR-2 and TLR-4 expression on monocytes from one patient is depicted (Figure 3).

View larger version (18K): [in this window] [in a new window]   Figure 2. Monocyte surface expression of CD14, TLR-2, and TLR-4 after CABG as measured by flow cytometry. Monocytes are stained with fluorescence-conjugated mAbs; data are presented as individual MFI values in percentage of preoperative value. Horizontal bars represent median values.

View larger version (24K): [in this window] [in a new window]   Figure 3. Monocyte surface expression of TLR-2 and TLR-4 after CABG. Flow cytometry linear-log scale histograms with fluorescence intensity (FI) on the x-axis plotted against cell counts. Result of one representative patient is shown. Cells were stained with Alexa488-conjugated mAbs against TLR-2 (TL2.1) and TLR-4 (HTA125).

In Vitro Studies
To explore the role of TLR-4 in HSP70 activation of cells, we used peritoneal macrophages from C3H/HeJ (tlr4 gene mutant) mice. As shown in Figure 4, macrophages from C3H/HeN (control) mice showed an HSP70 dose-dependent TNF response, whereas macrophages from the C3H/HeJ mice did not respond. LPS (a recognized TLR-4 ligand) stimulation gave corresponding results, whereas the lipopeptide 47L (which is known to stimulate cells through TLR-2) activated macrophages from both mouse strains.

View larger version (17K): [in this window] [in a new window]   Figure 4. TNF in supernatants of peritoneal macrophages from TLR-4 mutant (C3H/HeJ) and control (C3H/HeN) mice. Macrophages were stimulated with rhu HSP70, the synthetic lipoprotein 47L (10 µg/mL) or LPS (10 ng/mL) for 6 hours. TNF content was determined by means of a bioassay.

Human adherent monocytes stimulated with rhu HSP70 resulted in a dose-dependent release of TNF and IL-6 (Figure 5, A and B). Monoclonal antibodies against TLR-4 or CD14 inhibited the HSP70- and LPS-induced IL-6 response (Figure 5, C and D), whereas mAbs against TLR-2 did not. Polymyxin B did not inhibit the HSP70 response (Figure 5C), whereas the cytokine response to LPS was almost totally blocked (Figure 5D). In addition, RSLA blocked both HSP70- and LPS-induced cytokine production. Heat treatment (100°C for 20 minutes) almost completely abrogated HSP70-induced IL-6 production, whereas LPS still induced IL-6, although in some reduced amounts (data not shown).

View larger version (11K): [in this window] [in a new window]   Figure 5. A and B, Human adherent monocytes in RPMI (serum-free) stimulated with rhu HSP70. TNF and IL-6 in cell supernatants were measured by means of bioassays. One typical experiment out of at least 3 is shown. Data are presented as mean±SD of triplicate measurements. C and D, Monocytes stimulated with rhu HSP70 (3 µg/mL) or LPS (1 ng/mL), after preincubation with the monoclonal anti–TLR-2 (TL2.1), anti–TLR-4 (HTA125), and anti-CD14 (3C10) or co-incubation with Polymyxin B or RSLA. IL-6 measured as in A and B.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
The most important finding in the present study is the release of inducible HSP70 into the circulation after CABG. Furthermore, the in vitro studies suggest that TLR-4 is involved in HSP70 signaling.

It has been reported that ischemia and CABG induce HSP70 in myocardial cells.^7–9 However, there are few reports on circulating HSPs in human diseases.^23–25 The early peak of inducible HSP70 in plasma after CABG as demonstrated in our study is striking. Our study does not answer the question of which cells and tissues contribute to the circulating HSP70. One source could be myocardial and coronary artery endothelial cells stressed by ischemia or the surgical trauma. Another source of circulating HSP70 may be blood cells, damaged when circulating through the heart-lung machine. To elucidate this, a new study including blood samples of the coronary sinus is underway.

Extracellular HSP may indicate cell death (necrosis) and thus represents a danger signal.^26,27 Furthermore, it is now well documented that extracellular HSPs activate innate immunity, mediating an inflammatory response,^16–19 and our results are consistent with these reports. The postoperative inflammatory response in the study population was evident by the rise in plasma IL-6 up to 5 hours after surgery and by the persisting high concentration through days 1 and 2. The kinetics of the IL-6 response in our study population is comparable to results from other publications,^3,28 whereas the amount of IL-6 measured after surgery varies in different publications.^2–4 The difference in kinetics of IL-6 and HSP70 release after surgery as well as the correlation between the amount of IL-6 and HSP70 in each patient is interesting. It is tempting to speculate that the early HSP70 release may contribute to the IL-6 peak 5 hours after surgery. In vitro, we found that rhu HSP70 indeed induced monocyte IL-6 and TNF release in a dose-dependent manner.

Because extracellular HSPs induce synthesis of proinflammatory cytokines in vitro, it is important to identify the signaling receptors involved. CD14 appears to be involved in HSP60 and HSP70 signaling.^17–19 Sondermann et al,²⁹ however, considered the CD14-dependent activation of monocytes by HSP70 to occur downstream of specific receptor binding and/or uptake of HSP70. Involvement of TLR-4 in HSP signaling is previously shown only for HSP60,¹⁹ and CD91 has been suggested as a receptor for HSPs, including HSP70.^30,31 CD91 appears to be involved in the internalization of HSP-chaperoned peptides, necessary for the subsequent representation on the surface of antigen-presenting cells and activation of cytotoxic T cells. It is unclear whether CD91 is a signaling receptor, and HSP70 may possibly interact with other receptors mediating intracellular signaling and activation of innate immunity. Taken together, our results indicate that both TLR-4 and CD14 are involved in the HSP70-mediated proinflammatory response. Interestingly, Triantafilou et al³² recently presented evidence of a CD14-independent LPS receptor cluster that includes the constitutive forms of HSP70 and HSP90, among others. Thus, it may be that HSPs somehow must be involved in the activation of innate immunity, either in a circulating or a membrane bound form.

A major concern in this study is the possibility of LPS contamination of the rhu HSP70. According to the Limulus amebocyte lysate assay measurements, however, the LPS content is far below what is needed to obtain the amounts of IL-6 and TNF observed. Additionally, Polymyxin B did not inhibit HSP70 activation of monocytes in our experiments, in contrast to its effects on LPS. Furthermore, HSP70 shows strongly reduced activity, whereas LPS still shows a significant activity after heat treatment. Taken together, these findings indicate that the monocyte activation observed is due to unique properties of the HSP70 protein. TLR-4 is suggested as the central lipid A–recognition protein.¹³ The inhibitory effect of the lipid A analogue RSLA on both LPS and HSP70 supports the suggestion that HSP70 is signaling through TLR-4.

To our knowledge, no previous studies on TLR regulation in postoperative patients are published. However, monocyte CD14 expression after CABG is shown to be reduced the first postoperative day.³³ This downregulation of monocyte surface antigens probably represents a deactivation of monocytic proinflammatory functions,³⁴ and persistence of the deactivation may be associated with increasing risk of microbial invasion and infectious complications. We observed an initial downregulation of monocyte CD14, TLR-2, and TLR-4 after the CABG operation. Subsequently, CD14 normalized, whereas TLR-2 and TLR-4 were upregulated, suggesting monocyte activation by the CABG procedure. A decrease in monocyte count after initiation of CPB and monocytosis the morning after the CABG have been reported.^33,35 We observed a similar variation in our flow cytometry analyses (data not shown). This must be taken into account, evaluating the significance of monocyte surface receptor regulation.

In summary, the present study shows HSP70 release and regulation of TLR-2 and TLR-4 on monocytes after CABG. Extracellular HSP70 may act as an endogenous ligand for TLR-4, thus mediating an inflammatory response. The results of this study are compatible with the suggestion of HSPs as danger signals during trauma. In a clinical perspective, circulating HSPs as markers of tissue damage and ischemia may possibly become of diagnostic and prognostic advantage. However, further studies are necessary to clarify the receptors involved in signaling mediated by HSPs as well as the tissues responsible for HSP70 release.

	Acknowledgments

 
We are grateful to the staff at the St Elisabeth Heart Center, who made this study run so smoothly. Øyvind Halaas patiently answered questions during flow cytometry analyses, and Liv Ryan gave excellent technical assistance.

Received October 23, 2001; revision received December 3, 2001; accepted December 14, 2001.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Kirklin JK, Blackstone EH, Kirklin JW. Cardiopulmonary bypass: studies on its damaging effects. Blood Purif. 1987; 5: 168–178.
   
2. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996; 61: 1714–1720.
   
3. Fransen E, Maessen J, Dentener M, et al. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest. 1998; 113: 1290–1295.
   
4. Czerny M, Baumer H, Kilo J, et al. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg. 2000; 17: 737–742.
   
5. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s: systemic inflammatory response and organ dysfunction. JAMA. 1994; 271: 226–233.
   
6. Ohtsuka K, Hata M. Molecular chaperone function of mammalian HSP70 and HSP40: a review. Int J Hyperthermia. 2000; 16: 231–245.
   
7. Jäättelä M. Heat shock proteins as cellular lifeguards. Ann Med. 1999; 31: 261–271.
   
8. Valen G, Hansson GK, Dumitrescu A, et al. Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFB and AP-1. Cardiovasc Res. 2000; 47: 49–56.
   
9. Demidov ON, Tyrenko VV, Svistov AS, et al. Heat shock proteins in cardiosurgery patients. Eur J Cardiothorac Surg. 1999; 16: 444–449.
   
10. Poltorak A, Xialong H, Sminova I, et al. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998; 282: 2085–2088.
    
11. Chow JC, Young DW, Golenbock DT, et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999; 274: 10689–10692.
    
12. Shimazu R, Akashi S, Ogata H, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999; 189: 1777–1782.
    
13. Lien E, Means TK, Heine H, et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest. 2000; 105: 497–504.
    
14. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity. 1999; 11: 443–451.
    
15. Flo TH, Halaas Ø, Lien E, et al. Human Toll-like receptor 2 mediates monocyte activation by listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol. 2000; 164: 2064–2069.
    
16. Chen W, Syldath U, Bellmann K, et al. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol. 1999; 162: 3212–3219.
    
17. Kol A, Lichtman AH, Finberg RW, et al. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol. 2000; 164: 13–17.
    
18. Asea A, Kraeft S-K, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and a cytokine. Nat Med. 2000; 6: 435–442.
    
19. Ohashi K, Burkhart V, Flohé S, et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J Immunol. 2000; 164: 558–561.
    
20. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986; 95: 99–105.
    
21. Qureshi N, Jarvis BW, Takayama K. Nontoxic RsDPLA as a potent antagonist of toxic lipopolysaccharide.In: Brade H, Opal SM, Vogel SN, et al, eds. Endotoxin in Health and Disease. 1st ed. New York, NY: Marcel Dekker, Inc; 1999: 687–698.
    
22. Aarden LA, DeGroot ER, Schaap OL, et al. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987; 17: 1411–1416.
    
23. Wright BH, Corton JM, El-Nahas AM, et al. Elevated levels of circulating heat shock protein 70 (HSP70) in peripheral and renal vascular disease. Heart Vessels. 2000; 15: 18–22.
    
24. Xu Q, Schett G, Perschinka H, et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation. 2000; 102: 14–20.
    
25. Pockley AG, Wu R, Lemne C, et al. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension. 2000; 36: 303–307.
    
26. Srivastava PK, Menoret A, Basu S, et al. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity. 1998; 8: 657–665.
    
27. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994; 12: 991–1045.
    
28. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery. 2000; 127: 117–126.
    
29. Sondermann H, Becker T, Mayhew M, et al. Characterization of a receptor for heat shock protein 70 on macrophages and monocytes. Biol Chem. 2000; 381: 1165–1174.
    
30. Binder RJ, Han DK, Srivastava PK. CD91: a receptor for heat shock protein gp96. Nat Immun. 2000; 1: 151–155.
    
31. Basu S, Binder RJ, Ramalingan T, et al. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. 2001; 14: 303–313.
    
32. Triantafilou K, Triantafilou M, Dedrick RL. A CD14-independent LPS receptor cluster. Nat Immun. 2001; 2: 338–345.
    
33. Fingerle-Rowson G, Auers J, Kreuzer E, et al. Down-regulation of surface monocyte lipopolysaccharide-receptor CD14 in patients on cardiopulmonary bypass undergoing aorta-coronary bypass operation. J Thorac Cardiovasc Surg. 1998; 115: 1172–1178.
    
34. Volk H-D, Reinke P, Döcke W-D. Clinical aspects: from systemic inflammation to ‘immunoparalysis.’ Chem Immunol. 2000; 74: 162–177.
    
35. Ljunghusen O, Cederholm I, Lundahl J, et al. Phenotypic alterations in circulating monocytes induced by open heart surgery using heparinized and nonheparinized cardiopulmonary bypass systems. Artif Organs. 1997; 21: 1091–1097.
    

This article has been cited by other articles:

				J. Cha, Z. Wang, L. Ao, N. Zou, C. A. Dinarello, A. Banerjee, D. A. Fullerton, and X. Meng Cytokines link toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann. Thorac. Surg., May 1, 2008; 85(5): 1678 - 1685. [Abstract] [Full Text] [PDF]

				E. Doz, N. Noulin, E. Boichot, I. Guenon, L. Fick, M. Le Bert, V. Lagente, B. Ryffel, B. Schnyder, V. F. J. Quesniaux, et al. Cigarette Smoke-Induced Pulmonary Inflammation Is TLR4/MyD88 and IL-1R1/MyD88 Signaling Dependent J. Immunol., January 15, 2008; 180(2): 1169 - 1178. [Abstract] [Full Text] [PDF]

				J. Feng and F. W. Sellke Invited commentary Ann. Thorac. Surg., January 1, 2008; 85(1): 87 - 88. [Full Text] [PDF]

				H. Shao, Y. Shen, H. Liu, G. Dong, J. Qiang, and H. Jing Simvastatin Suppresses Lung Inflammatory Response in a Rat Cardiopulmonary Bypass Model Ann. Thorac. Surg., December 1, 2007; 84(6): 2011 - 2018. [Abstract] [Full Text] [PDF]

				M. A. Chase, D. S. Wheeler, K. M. Lierl, V. S. Hughes, H. R. Wong, and K. Page Hsp72 Induces Inflammation and Regulates Cytokine Production in Airway Epithelium through a TLR4- and NF-{kappa}B-Dependent Mechanism J. Immunol., November 1, 2007; 179(9): 6318 - 6324. [Abstract] [Full Text] [PDF]

				J.-F. Legare, A. Oxner, O. Heimrath, T. Myers, and R. W. Currie Heat shock treatment results in increased recruitment of labeled PMN following myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3210 - H3215. [Abstract] [Full Text] [PDF]

				M. T. Bailey, H. Engler, N. D. Powell, D. A. Padgett, and J. F. Sheridan Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1180 - R1190. [Abstract] [Full Text] [PDF]

				S.-C. Tang, T. V. Arumugam, X. Xu, A. Cheng, M. R. Mughal, D. G. Jo, J. D. Lathia, D. A. Siler, S. Chigurupati, X. Ouyang, et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits PNAS, August 21, 2007; 104(34): 13798 - 13803. [Abstract] [Full Text] [PDF]

				F. Hua, T. Ha, J. Ma, Y. Li, J. Kelley, X. Gao, I. W. Browder, R. L. Kao, D. L. Williams, and C. Li Protection against Myocardial Ischemia/Reperfusion Injury in TLR4-Deficient Mice Is Mediated through a Phosphoinositide 3-Kinase-Dependent Mechanism J. Immunol., June 1, 2007; 178(11): 7317 - 7324. [Abstract] [Full Text] [PDF]

				M.-F. Tsan and Baochong Gao Review: Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors Innate Immunity, February 1, 2007; 13(1): 6 - 14. [Abstract] [PDF]

				E. Bennett-Guerrero, H. P. Grocott, J. H. Levy, K. A. Stierer, C. W. Hogue, A. T. Cheung, M. F. Newman, A. A. Carter, D. P. Rossignol, and C. D. Collard A Phase II, Double-Blind, Placebo-Controlled, Ascending-Dose Study of Eritoran (E5564), a Lipid A Antagonist, in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass Anesth. Analg., February 1, 2007; 104(2): 378 - 383. [Abstract] [Full Text] [PDF]

				A. Linde, D. Mosier, F. Blecha, and T. Melgarejo Innate immunity and inflammation - New frontiers in comparative cardiovascular pathology Cardiovasc Res, January 1, 2007; 73(1): 26 - 36. [Abstract] [Full Text] [PDF]

				R. Aneja, K. Odoms, K. Dunsmore, T. P. Shanley, and H. R. Wong Extracellular Heat Shock Protein-70 Induces Endotoxin Tolerance in THP-1 Cells J. Immunol., November 15, 2006; 177(10): 7184 - 7192. [Abstract] [Full Text] [PDF]

				L. Romics Jr, G. Szabo, J. C. Coffey, J. H. Wang, and H. P. Redmond The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases Arch Surg, June 1, 2006; 141(6): 595 - 601. [Abstract] [Full Text] [PDF]

				V. Cavalca, E. Sisillo, F. Veglia, E. Tremoli, G. Cighetti, L. Salvi, A. Sola, L. Mussoni, P. Biglioli, G. Folco, et al. Isoprostanes and Oxidative Stress in Off-Pump and On-Pump Coronary Bypass Surgery Ann. Thorac. Surg., February 1, 2006; 81(2): 562 - 567. [Abstract] [Full Text] [PDF]

				F.C. Gibson III, H. Yumoto, Y. Takahashi, H.-H. Chou, and C.A. Genco Innate Immune Signaling and Porphyromonas gingivalis-accelerated Atherosclerosis J. Dent. Res., February 1, 2006; 85(2): 106 - 121. [Abstract] [Full Text] [PDF]

				T. Ha, Y. Li, F. Hua, J. Ma, X. Gao, J. Kelley, A. Zhao, G. E. Haddad, D. L. Williams, I. William Browder, et al. Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload Cardiovasc Res, November 1, 2005; 68(2): 224 - 234. [Abstract] [Full Text] [PDF]

				M. L. Kielar, R. John, M. Bennett, J. A. Richardson, J. M. Shelton, L. Chen, D. R. Jeyarajah, X. J. Zhou, H. Zhou, B. Chiquett, et al. Maladaptive Role of IL-6 in Ischemic Acute Renal Failure J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3315 - 3325. [Abstract] [Full Text] [PDF]

				F. J. Quintana and I. R. Cohen Heat Shock Proteins as Endogenous Adjuvants in Sterile and Septic Inflammation J. Immunol., September 1, 2005; 175(5): 2777 - 2782. [Abstract] [Full Text] [PDF]

				G. Foteinos, A. R. Afzal, K. Mandal, M. Jahangiri, and Q. Xu Anti-Heat Shock Protein 60 Autoantibodies Induce Atherosclerosis in Apolipoprotein E-Deficient Mice via Endothelial Damage Circulation, August 23, 2005; 112(8): 1206 - 1213. [Abstract] [Full Text] [PDF]

				Y. Sato, Y. Hiramatsu, S. Homma, M. Sato, S. Sato, S. Endo, and Y. Sohara Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 346 - 350. [Abstract] [Full Text] [PDF]

				W. Chao, Y. Shen, X. Zhu, H. Zhao, M. Novikov, U. Schmidt, and A. Rosenzweig Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation J. Biol. Chem., June 10, 2005; 280(23): 21997 - 22005. [Abstract] [Full Text] [PDF]

				R. Liu-Bryan, K. Pritzker, G. S. Firestein, and R. Terkeltaub TLR2 Signaling in Chondrocytes Drives Calcium Pyrophosphate Dihydrate and Monosodium Urate Crystal-Induced Nitric Oxide Generation J. Immunol., April 15, 2005; 174(8): 5016 - 5023. [Abstract] [Full Text] [PDF]

				G. I Lancaster, Q. Khan, P. Drysdale, F. Wallace, A. E Jeukendrup, M. T Drayson, and M. Gleeson The physiological regulation of toll-like receptor expression and function in humans J. Physiol., March 15, 2005; 563(3): 945 - 955. [Abstract] [Full Text] [PDF]

				B Dybdahl, S A Slordahl, A Waage, P Kierulf, T Espevik, and A Sundan Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction Heart, March 1, 2005; 91(3): 299 - 304. [Abstract] [Full Text] [PDF]

S. Vogt, I. Portig, B. Kusch, S. Pankuweit, A. S. Sirat, D. Troitzsch, B. Maisch, and R. Moosdorf Detection of anti-hsp70 immunoglobulin G antibodies indicates better outcome in coronary artery bypass grafting patients suffering from severe preoperative angina Ann. Thorac. Surg., September 1, 2004; 78(3): 883 - 889. [Abstract] [Full Text] [PDF]

<